BRPI0810496A2 - inibidores de transcriptase reversa de não-nucleosídeo - Google Patents

inibidores de transcriptase reversa de não-nucleosídeo

Info

Publication number: BRPI0810496A2
Authority: BR; Brazil
Prior art keywords: reverse transcriptase; transcriptase inhibitors; nucleoside reverse; nucleoside; inhibitors
Prior art date: 2007-04-09

Application number

BRPI0810496A

Other languages

English (en)

Inventor

Wu Jeffrey

J Billedeau Roland

Solang Palmer Wylie

Kevin Sweeney Zachary

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-04-09

Filing date

2008-03-31

Publication date

2018-11-06

2008-03-31 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2018-11-06 Publication of BRPI0810496A2 publication Critical patent/BRPI0810496A2/pt

Links

229940042402 non-nucleoside reverse transcriptase inhibitor Drugs 0.000 title 1
239000002726 nonnucleoside reverse transcriptase inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

BRPI0810496A 2007-04-09 2008-03-31 inibidores de transcriptase reversa de não-nucleosídeo BRPI0810496A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US92244907P	2007-04-09	2007-04-09
US96134607P	2007-07-20	2007-07-20
PCT/EP2008/053806 WO2008122534A2 (en)	2007-04-09	2008-03-31	Non-nucleoside reverse transcriptase inhibitors

Publications (1)

Publication Number	Publication Date
BRPI0810496A2 true BRPI0810496A2 (pt)	2018-11-06

Family

ID=39798124

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0810496A BRPI0810496A2 (pt)	2007-04-09	2008-03-31	inibidores de transcriptase reversa de não-nucleosídeo

Country Status (15)

Country	Link
US (1)	US20080293664A1 (pt)
EP (1)	EP2134711A2 (pt)
JP (1)	JP2010523613A (pt)
KR (1)	KR20100015435A (pt)
CN (1)	CN101679414A (pt)
AR (1)	AR066404A1 (pt)
AU (1)	AU2008235549A1 (pt)
BR (1)	BRPI0810496A2 (pt)
CA (1)	CA2683046A1 (pt)
CL (1)	CL2008000996A1 (pt)
IL (1)	IL200886A0 (pt)
MX (1)	MX2009010932A (pt)
PE (1)	PE20090143A1 (pt)
TW (1)	TW200906410A (pt)
WO (1)	WO2008122534A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1838152A2 (en) *	2005-01-21	2007-10-03	Neurogen Corporation	Imidazolylmethyl and pyrazolylmethyl heteroaryl derivatives
JP5269087B2 (ja) *	2007-11-16	2013-08-21	ギリアードサイエンシスインコーポレーテッド	ヒト免疫不全ウイルス複製のインヒビター
RU2495878C2 (ru) *	2007-12-21	2013-10-20	Ф.Хоффманн-Ля Рош Аг	Гетероциклические антивирусные соединения
CN103025696B (zh)	2010-07-15	2015-08-12	阿尔比马尔公司	用于制备4-溴代-2-甲氧基苯甲醛的方法
US9497234B2 (en)	2012-12-27	2016-11-15	Facebook, Inc.	Implicit social graph connections
WO2016004272A1 (en) *	2014-07-02	2016-01-07	Pharmacyclics Llc	Inhibitors of bruton's tyrosine kinase

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0128287D0 (en) *	2001-11-26	2002-01-16	Smithkline Beecham Plc	Novel method and compounds
GB0206723D0 (en) *	2002-03-21	2002-05-01	Glaxo Group Ltd	Novel compounds
EP1608629A1 (en) *	2003-03-24	2005-12-28	F. Hoffmann-La Roche Ag	Benzyl-pyridazinons as reverse transcriptase inhibitors
TW200505441A (en) *	2003-03-24	2005-02-16	Hoffmann La Roche	Non-nucleoside reverse transcriptase inhibitorsⅠ
CA2559552A1 (en) *	2004-03-23	2005-09-29	F. Hoffmann-La Roche Ag	Benzyl-pyridazinone derivatives as non-nucleoside reverse transcriptase inhibitors
US7166738B2 (en) *	2004-04-23	2007-01-23	Roche Palo Alto Llc	Non-nucleoside reverse transcriptase inhibitors
US7625949B2 (en) *	2004-04-23	2009-12-01	Roche Palo Alto Llc	Methods for treating retroviral infections
SG148179A1 (en) *	2004-07-27	2008-12-31	Hoffmann La Roche	Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors
AR057455A1 (es) *	2005-07-22	2007-12-05	Merck & Co Inc	Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
DK2057125T3 (da) *	2006-08-16	2011-05-16	Hoffmann La Roche	Ikke-nucleosid revers transkriptase-inhibitorer

2008
- 2008-03-31 AU AU2008235549A patent/AU2008235549A1/en not_active Abandoned
- 2008-03-31 KR KR1020097021022A patent/KR20100015435A/ko not_active Withdrawn
- 2008-03-31 WO PCT/EP2008/053806 patent/WO2008122534A2/en not_active Ceased
- 2008-03-31 JP JP2010502486A patent/JP2010523613A/ja active Pending
- 2008-03-31 CN CN200880011097A patent/CN101679414A/zh active Pending
- 2008-03-31 CA CA002683046A patent/CA2683046A1/en not_active Abandoned
- 2008-03-31 EP EP08735604A patent/EP2134711A2/en not_active Withdrawn
- 2008-03-31 BR BRPI0810496A patent/BRPI0810496A2/pt not_active Application Discontinuation
- 2008-03-31 MX MX2009010932A patent/MX2009010932A/es not_active Application Discontinuation
- 2008-04-07 AR ARP080101433A patent/AR066404A1/es unknown
- 2008-04-07 CL CL200800996A patent/CL2008000996A1/es unknown
- 2008-04-07 PE PE2008000622A patent/PE20090143A1/es not_active Application Discontinuation
- 2008-04-08 US US12/082,069 patent/US20080293664A1/en not_active Abandoned
- 2008-04-08 TW TW097112675A patent/TW200906410A/zh unknown
2009
- 2009-09-13 IL IL200886A patent/IL200886A0/en unknown

Also Published As

Publication number	Publication date
MX2009010932A (es)	2009-10-29
WO2008122534A3 (en)	2009-02-05
AR066404A1 (es)	2009-08-19
WO2008122534A2 (en)	2008-10-16
AU2008235549A1 (en)	2008-10-16
EP2134711A2 (en)	2009-12-23
CL2008000996A1 (es)	2008-10-10
KR20100015435A (ko)	2010-02-12
IL200886A0 (en)	2010-05-17
US20080293664A1 (en)	2008-11-27
TW200906410A (en)	2009-02-16
CN101679414A (zh)	2010-03-24
JP2010523613A (ja)	2010-07-15
CA2683046A1 (en)	2008-10-16
PE20090143A1 (es)	2009-02-26

Legal Events

Date	Code	Title	Description
2018-11-13	B11A	Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
2019-01-29	B11Y	Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]

Publication	Publication Date	Title
BRPI0813269A2 (pt)	2014-12-30	Inibidores de hiv transcriptase reversa
BRPI0715193A2 (pt)	2013-10-01	inibidores nço-nucleosÍdicos da transcriptase reversa
ZA200903395B (en)	2010-05-26	Non-nucleoside reverse transcriptase inhibitors
EP2076492A4 (en)	2010-12-22	NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS
IL205386A0 (en)	2010-12-30	Non - nucleoside reverse transcriptase inhibitors
LTPA2019506I1 (lt)	2019-04-25	Nenukleozidinės reversinės transkriptazės inhibitoriai
EP2217069A4 (en)	2012-03-14	INHIBITORS OF NON-NUCLEOSIDE INHIBITORS OF THE REVERSE TRANSCRIPTASE
CY2017016I2 (el)	2017-07-12	Αναστολεις πρωτεασωματος
EP2220091A4 (en)	2011-04-27	REVERSE transcriptase inhibitors
IL200748A0 (en)	2010-05-17	Non-nucleoside reverse transcriptse inhibitors
BRPI0818294A2 (pt)	2015-11-03	refrigerador
NO20161397A1 (no)	2016-09-02	Ikke-nukleosidbaserte revers-transkriptase-inhibitorer
DK2139892T3 (da)	2011-12-12	Substituerede pyrimidodiazepiner nyttige som PLK1-inhibitorer
DK2383271T3 (da)	2013-10-07	Aminoquinoloner som GSK-3-inhibitorer
BRPI0819260A2 (pt)	2015-09-08	refrigerador
DK2220070T3 (da)	2011-07-04	2-benzylpyridazinonderivater som Met-kinaseinhibitorer
BRPI0820345A2 (pt)	2015-09-22	refrigerador
EP2226593A4 (en)	2010-09-08	FREEZER UNIT
EP2204584A4 (en)	2014-12-31	Screw fluid machine
BRPI0811645A2 (pt)	2014-11-11	Inibidores de transcriptase reversa de não-nucleosídeo
BRPI0810496A2 (pt)	2018-11-06	inibidores de transcriptase reversa de não-nucleosídeo
BRPI0714509A2 (pt)	2014-04-08	Inibidores de transcriptase reversa de não-nucleosídeo.
ATE522533T1 (de)	2011-09-15	Pyrazolopyrimidinonkinaseinhibitor
EP1899340A4 (en)	2009-09-16	NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS
FI20075320A0 (fi)	2007-05-07	Uusia käyttökelpoisia inhibiittoreita